Ashok Leyland DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.72×0.73×0.74×0.66×0.60×
0.53×0.53×0.56×0.58×0.54×
17.0%17.0%16.7%15.3%10.1%
0.62×0.62×0.65×0.75×0.85×
5.45×5.45×5.16×5.73×5.07×
21.8%22.3%23.4%25.3%14.1%
26.2%26.2%29.3%28.3%15.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ASHOKLEY₹145.60

Ashok Leyland Ltd.

· Capital Goods & Defence
₹ CrorePeersEICHERMOTSUZLONBHELAPLAPOLLOPOLYCABGVT&DTMCVMAZDOCKMcap ₹85,524 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.600.660.740.730.72
Interest Burden (Pretax/EBIT) ×0.540.580.560.530.53
EBIT Margin %10.0615.3216.7317.0516.98
Asset Turnover ×0.850.750.650.620.62
Financial Leverage (Assets/Equity) ×5.075.735.165.455.45
ROE (5-step product, year-end total equity) %14.0825.2923.3622.3021.83
ROE (owners' profit / average owners' equity) %15.6528.2929.2626.2226.22
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.